Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Hollings Renton currently holds 20,925 shares of PORTOLA PHARMACEUTICALS INC (PTLA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Hollings Renton has been a net seller of PTLA stock. They have purchased $0 and sold $15.4M worth of shares.
Hollings Renton's most recent insider trade was on Nov 29, 2024, when they sold 10,000 shares at $0.00 per share.
Hollings Renton serves as Executive at PORTOLA PHARMACEUTICALS INC (PTLA). They have executed 170 insider transactions totaling $15.4M over their tenure at the company.
Hollings Renton holds the position of Executive at PORTOLA PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
Hollings Renton has shown a selling trading pattern, with $0 in total purchases and $15.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Hollings Renton was on Oct 20, 2014, when they sold $545.4K worth of CPHD shares. This transaction involved 11,900 shares at $45.83 per share.
Hollings Renton currently owns 20,925 shares of PORTOLA PHARMACEUTICALS INC (PTLA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Hollings Renton's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Hollings Renton has 170 Form 4 filings on record as an insider at PORTOLA PHARMACEUTICALS INC.
Set alerts for Hollings Renton and 40,000+ other insiders.